Stocks and Investing Stocks and Investing
Mon, October 5, 2020
Sun, October 4, 2020

Brian Abrahams Maintained (VRTX) at Hold and Held Target at $276 on, Oct 4th, 2020


Published on 2024-10-27 14:00:38 - WOPRAI, Brian Abrahams
  Print publication without navigation


Brian Abrahams of RBC Capital, Maintained "Vertex Pharmaceuticals Incorporated" (VRTX) at Hold and Held Target at $276 on, Oct 4th, 2020.

Brian has made no other calls on VRTX in the last 4 months.



There are 9 other peers that have a rating on VRTX. Out of the 9 peers that are also analyzing VRTX, 2 agree with Brian's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Geoffrey Porges of "SVB Leerink" Maintained at Hold with Increased Target to $283 on, Monday, August 24th, 2020
  • Matthew Harrison of "Morgan Stanley" Downgraded from Buy to Hold and Increased Target to $300 on, Wednesday, July 8th, 2020


These are the ratings of the 7 analyists that currently disagree with Brian


  • Alethia Young of "Cantor Fitzgerald" Maintained at Buy with Increased Target to $305 on, Friday, July 31st, 2020
  • Andrew Fein of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $315 on, Friday, July 31st, 2020
  • Paul Matteis of "Stifel" Maintained at Strong Buy with Increased Target to $309 on, Friday, July 31st, 2020
  • Gena Wang of "Barclays" Maintained at Buy with Increased Target to $315 on, Friday, July 31st, 2020
  • Evan Seigerman of "Credit Suisse" Maintained at Buy with Increased Target to $328 on, Monday, July 20th, 2020
  • Salveen Richter of "Goldman Sachs" Maintained at Strong Buy with Increased Target to $330 on, Thursday, July 2nd, 2020
  • Robyn Karnauskas of "Citigroup" Maintained at Strong Buy with Increased Target to $325 on, Friday, June 12th, 2020
Contributing Sources